These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 7788891)

  • 21. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro sensitivity of Entamoeba histolytica to metronidazole].
    Aguirre-Cruz ML; Valadez-Salazar A; Muñoz O
    Arch Invest Med (Mex); 1990; 21 Suppl 1():23-6. PubMed ID: 2136490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutically active anthraquinones. I. Aminoanthraquinones.
    Winkelmann E; Raether W
    Arzneimittelforschung; 1979; 29(10):1504-9. PubMed ID: 229867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.
    Debbia EA; Campora U; Massaro S; Boldrini E; Schito GC
    J Chemother; 1996 Apr; 8(2):96-101. PubMed ID: 8708753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and antiparasitic activity of new nitro-5-imidazole derivatives].
    Quattara L; Debaert M; Cavier R
    Farmaco Sci; 1987 Jun; 42(6):449-56. PubMed ID: 2888689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacologic study of the amebicidal and trichomonicidal activity of ornidazole (1-(2-hydroxy-3-chloropropyl)-2-methyl-5-nitroimidazole].
    Savel J
    Ann Pharm Fr; 1976; 34(7-8):249-59. PubMed ID: 188370
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
    Meingassner JG; Nesvadba H; Mieth H
    Arzneimittelforschung; 1981; 31(1):6-8. PubMed ID: 6971111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichomonas vaginalis: determination of acid phosphatase activity as a pharmacological screening procedure.
    Martínez-Grueiro MM; Montero-Pereira D; Giménez-Pardo C; Nogal-Ruiz JJ; Escario JA; Gómez-Barrio A
    J Parasitol; 2003 Oct; 89(5):1076-7. PubMed ID: 14627165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents.
    Alves AJ; Leite AC; De Santana DP; Beltrao TM; Coelho MR; Gayral P
    Farmaco; 1993 Aug; 48(8):1167-71. PubMed ID: 8216678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological assay of potential trichomonacides in vitro using a counter apparatus.
    Brotherton J
    Arzneimittelforschung; 1978; 28(10):1665-72. PubMed ID: 314804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles.
    Hernández-Núñez E; Tlahuext H; Moo-Puc R; Torres-Gómez H; Reyes-Martínez R; Cedillo-Rivera R; Nava-Zuazo C; Navarrete-Vazquez G
    Eur J Med Chem; 2009 Jul; 44(7):2975-84. PubMed ID: 19208443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.